Related Experiment Video

Updated: Sep 26, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Endomyocardial fibrosis in infancy

Marcelo Biscegli Jatene1, Ivan Salvador Bonillo Contreras, Laura C Riera Lameda

  • 1Divisão Cirúrgica, Setor de Cirurgia Cardíaca Pediátrica, Instituto do Coração, Hospital das Clínicas, FMUSP, Sao Paulo, SP, Brazil. mbjatene@uol.com.br

Arquivos Brasileiros De Cardiologia
|May 20, 2003
PubMed

Insights

This case study details an infant with endomyocardial fibrosis, a rare condition causing heart dysfunction and hypoxia. Despite surgical intervention, the infant experienced complications and ultimately passed away.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Pathology
  • Infant Health

Background:

  • A 4-month-old infant presented with recurrent hypoxia and hypertonicity starting at 2 months.
  • The infant had previously undergone surgical closure of a persistent ductus arteriosus at 13 days old.

Observation:

  • Clinical investigation confirmed pulmonary hypertension.
  • Left ventricular inflow tract obstruction was suspected.
  • Surgical exploration at 4 months revealed endocardial fibrosis in both ventricles.

Findings:

  • Surgical resection of endocardial fibrosis was performed.
  • The infant experienced severe diastolic restriction post-surgery.
  • Anatomicopathological findings supported endomyocardial fibrosis, a rare diagnosis in infants.

Implications:

  • This case highlights the challenges in diagnosing and managing rare pediatric cardiac conditions like endomyocardial fibrosis.
  • Early identification and treatment strategies for infant endomyocardial fibrosis require further investigation.
  • Understanding the etiology of endomyocardial fibrosis in neonates and infants is crucial for improving outcomes.

More Related Videos

A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition08:38

A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition

Published on: July 21, 2023

Analysis of Cardiomyocyte Development using Immunofluorescence in Embryonic Mouse Heart10:56

Analysis of Cardiomyocyte Development using Immunofluorescence in Embryonic Mouse Heart

Published on: March 26, 2015

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...